Richardson Healthcare Limited

Richardson Healthcare Limited is a specialized medical products company focused on wound care management, emphasizing solutions that combat wound malodour and excessive exudate for healthcare providers. Richardson Healthcare Limited, founded in 2001, delivers innovative solutions for wound care management. The company operates globally, with headquarters located in the United Kingdom. It has seen consistent growth in its business strategy, focusing on providing advanced wound care products to healthcare institutions.

Richardson Healthcare Ltd specializes in a comprehensive range of medical products aimed at wound care, particularly focusing on managing wound malodour and excessive exudate. Their core offerings include advanced wound care solutions such as C-Sorb, C-Sorb Carbon, and C-Foam products, designed to address challenges faced in clinical settings, including the treatment of pressure ulcers and skin tears. The company serves healthcare professionals and institutions like hospitals and clinics, primarily in Europe, North America, and parts of Asia. Richardson Healthcare Ltd operates on a B2B model, supplying its medical products directly to healthcare providers, including hospitals, clinics, and long-term care facilities.

The company generates revenue through the sale of its specialized wound care products, primarily through bulk orders and contracts for supply. Their flagship products, such as the C-Sorb line, are typically sold on a per-unit basis to institutional clients, supporting long-term relationships with healthcare providers.